Skip to main content

Market Overview

Why Corvus Pharmaceuticals, Prothena, CollPlant Are Moving Today

Share:
Why Corvus Pharmaceuticals, Prothena, CollPlant Are Moving Today

Corvus Pharmaceuticals (NASDAQ: CRVS) shares are trading lower Friday after the company priced its 8.571 million share common stock offering at $3.50 per share.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing small-molecule and antibody agents that target the immune system to treat patients with cancer. The firm's pipeline includes CPI-006, CPI-818, CPI-935, and others.

Corvus Pharmaceuticals shares were trading down 10.15% at $3.54. The stock has a 52-week high of $6.88 and a 52-week low of $1.01.

See also: Best Pharma ETFs

CollPlant (NASDAQ: CLGN) shares are trading lower after the company priced its registered direct offering of 2 million american depositary shares at $17.50 per ADS.

CollPlant Biotechnologies Ltd is a regenerative medicine company. It is focused on developing and commercializing tissue repair products, initially for 3D-bio printing of tissues and organs, dermal fillers for aesthetics, orthobiologics, and advanced wound care markets.

CollPlant shares were trading down 33.81% at $16.05. The stock has a 52-week high of $24.26 and a 52-week low of $6.

Prothena (NASDAQ/;PRTA) shares are trading higher after Jefferies today upgraded the stock from Hold to Buy and raised its price target from $15 to $30 following the company's Q4 earnings report yesterday.

Prothena Corp PLC is a biotechnology company focuses on the discovery, development, and commercialization of novel protein immunotherapies for the treatment of diseases that involve protein misfolding and inflammatory cell adhesion disorders.

Prothena shares were trading up 30.57% at $20.50. The stock has a 52-week high of $20.85 and a 52-week low of $7.10.

 

Related Articles (CRVS + CLGN)

View Comments and Join the Discussion!

Posted-In: News Penny Stocks Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com